Re:23andMe to share customer gene data with GlaxoSmithKline ...
by LanceH on Tuesday December 17, 2019 @08:06PM
(#21820812)
So if things were different, they would be different.
Re:23andMe to share customer gene data with GlaxoSmithKline ...
by zepto on Tuesday December 17, 2019 @11:30PM
(#21821815)
What value are you adding with this meaningless comment?
I was refuting the parent’s point:
“any change like that would be major national news, debated extensively in Congress, and then, if turned into a new law, would roll out over years.
Which is manifestly false for the reasons I outlined.
Are you suggesting otherwise?
Re:23andMe to share customer gene data with GlaxoSmithKline ...
by dekhn on Wednesday December 18, 2019 @10:46AM
(#21826000)
The problem is you gave a single anecdotal example, and there was a bunch of attention paid at the time anyway and lots of people complained.
You can't insert major changes to health laws in omnibus spending bills.
Re:23andMe to share customer gene data with GlaxoSmithKline ...
by zepto on Wednesday December 18, 2019 @10:58AM
(#21826146)
There is nothing anecdotal about it, since it is a fact.
Almost nobody complained, there was no meaningful mainstream coverage, and most people don’t even know there was a change even now.
And you don’t need to insert a major change to punch a hole in the law. A small exception will do it.
There can easily be a hole punched in the law with some weasel words in an omnibus bill that nobody pays attention to until 5 years later and we are hearing about the problems in a 60 minutes exclusive.